Associate Director, Biostatistics in Maidenhead

The Associate Director (AD), Biostatistics, leads the full scope of statistical contribution to a clinical development program. The AD provides statistical strategies for the clinical trials and regulatory submissions, and is accountable for the statistical deliverables within the program.

Key Responsibilities:

• Lead full scope of Biostatistics conduct for the responsible program within a therapeutic area.
• Define statistical strategy and ensure appropriate statistical methodologies are applied to study design and data analysis for clinical trials and regulatory submissions.
• Influence and contribute to clinical development plans, collaborating with cross-functional teams for governance reviews.
• Lead statistical strategy for planning and study execution as a member of the Study Executive Team and Clinical Development Team.
• Provide statistical thought partnership for innovative study design and clinical development plans, including Go-No Go criteria and probability of technical success calculations.
• Ensure project-wide planning of analyses; quality and timely delivery of interim and final results, including integrated analyses for submissions.
• Represent Biostatistics in interactions with regulatory authorities (e.g., FDA, EMA, PMDA).
• Interpret analysis results and ensure reporting accuracy in study reports and regulatory documents.
• Manage outsourcing operations or work with internal statistical programmers within the responsible program.
• Ensure timeliness and quality of deliverables by CRO/FSP.
• Support or lead improvement initiatives within the department, organization and/or pharma industry.
• Prepare abstracts, posters, oral presentations and written reports to effectively communicate results of clinical programs and studies to internal and external stakeholders and colleagues with varying levels of clinical research knowledge.

Experience and Qualifications:

• Education: PhD or MS in Biostatistics, Statistics or related field.
• Experience: PhD with 8 years of experience or MS with 11 years of experience in drug development.
• Experience providing statistical leadership at compound/indication level.
• Demonstrated statistical expertise and leadership in facilitating and optimizing the (pre/early/full-) clinical development strategy.
• Solid experience in applications of advanced statistical methodologies.
• Leading roles in regulatory submissions.
• Experience in interactions with major regulatory authorities preferred.
• Experience with CROs (either managing a CRO, or having worked in a CRO) or managing internal deliveries preferred.
• Track record of innovation preferred.

Competencies:

• Familiarity with regulatory guidance and interactions.
• Broad knowledge of clinical development and processes.
• Ability to collaboratively work and provide leadership in a matrix environment.
• Strong interpersonal and communication skills (verbal and written in English).
• Good working knowledge of SAS and/or R.
• Expertise in a range of statistical methodologies.
• Demonstrated use of innovative/creative methodology for analysis of clinical data.
• Familiarity with relevant regulatory guidance documents.
• Expertise in CDISC, statistical programming, and/or data standards.

About CSL Behring:

CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives. CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries.